Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by maryjanemikeon Oct 05, 2018 11:01pm

182 Views

Post# 28756547

40 million in volume the last 2 days

I`m sticking around for a while on this company. I think consumers will demand that retailers get cbd beverages on shelf. Let`s face it ,most of us want to try it . CBD is produced form hemp...green goodness...restore,rejuvente....REFRESH.... I just gave NF their marketing PITCH...and I think its going to 50-1.00 fast

Bullboard Posts

Global Tungsten Market and Supply Security